Select a category

Video director TG Omori has said he’ll be up soon.

He made this promised after Kidney transplant surgery.

Continue reading on Instablog

Major U.S. equities indexes ticked higher ahead of a potentially consequential earnings report from semiconductor giant Nvidia (NVDA) as well as key inflation and economic data set for release later in the week.

The S&P 500 and the Nasdaq both closed Tuesday's session around 0.2% higher. The Dow's minimal gain of less than 0.1% was enough to secure a second straight record high at close for the blue-chip index.

Shares of medical device maker ResMed (RMD) logged the top performance of any stock in the S&P 500 on Tuesday, soaring 7.3%. A recent report from Transparency Market Research predicted a solid 8.5% compound annual growth rate (CAGR) for the sleep apnea devices market, where ResMed is a major player. Researchers believe government efforts to regulate sleep disorders, improved diagnostic processes, and aging global populations will drive market growth. In addition, Zacks Equities Research recently highlighted ResMed as a top momentum stock, citing an ongoing uptrend combined with strong earnings fundamentals.

ResMed was not the only medical technology provider that enjoyed a positive trading day. Insulet (PODD) shares jumped 6.6% after the Food and Drug Administration (FDA) cleared the company's Omnipod 5 insulin pump for use by patients with type 2 diabetes. The approval makes Omnipod 5 the first automated insulin delivery system to receive a green light from regulators for managing both type 1 and type 2 diabetes.

Shares companies across the travel industry moved higher after Singapore-based travel platform Trip.com (TCOM) posted better-than-expected quarterly sales and profits, boosted by a growing number of travelers and strong cross-border demand in Chinese markets. In addition, a report by Zacks Equities Research said strong booking and pricing trends could drive near-term growth for cruise operators. Shares of Royal Caribbean Cruises (RCL), Norwegian Cruise Line (NCLH), and Carnival (CCL) gained 4.3%, 3.6%, and 2.7%, respectively.

Walgreens Boots Alliance (WBA) shares tumbled 9.0%, suffering the steepest daily loss in the S&P 500. The pharmacy giant's stock dropped after Eli Lilly (LLY) announced plans to launch a cheaper version of its popular weight-loss treatment, which could have a negative impact on Walgreens sales. The company is also navigating challenges related to lower reimbursement rates for prescription drugs, as well as high levels of inflation and competition.

Paramount Global (PARA) shares slid 7.2% after reports media executive Edgar Bronfman Jr. withdrew his proposal to purchase the entertainment firm. Uncertainties about how he would finance the deal reportedly contributed to Bronfman's decision to abandon the bid. Following Bronfman's exit, Paramount now appears set to move forward with its previously agreed-upon deal to be acquired by production company Skydance Media.

Shares of building materials provider Martin Marietta Materials (MLM) sank 4.3%. Although Morgan Stanley boosted its price target on the stock, citing predicted strength in the U.S. cement market, reports of significant share sales by company insiders suggest a potential lack of confidence in the firm's upcoming performance. Shares of industry peer Vulcan Materials (VMC) were down 4.1% on the day.

Read more on Investopedia

About OPay

Continue reading on Instablog

Shares of travel-industry companies moved higher on Tuesday, lifted by the news that Trip.com Group (TCOM), the largest online travel service in China, topped sales and profit estimates for the second quarter.

Signs of resilience in the Chinese travel market in Trip.com's report, driven by demand for cross-border travel, helped boost several U.S.-based travel stocks. Cruise operators Norwegian Cruise Line (NCLH), Royal Caribbean Cruises (RCL), and Carnival (CCL) all rose, as did online travel platform Expedia (EXPE).

Trip.com reported a 14% year-over-year increase in revenue in the second quarter. A higher number of people traveling in China—especially in the periods surrounding holidays—contributed to the strong sales performance. The company generated sales growth across all its revenue categories: accommodation, transportation ticketing, package tours, and corporate travel.

Trip.com's American Depository Receipts (ADRs) soared 8.6% in Tuesday's session following the strong earnings results. The upbeat results and indications of buoyant travel demand helped brighten the outlook for travel companies in the U.S.

A report by Zacks Equities Research, published Tuesday, highlighted numerous positives for cruise operators, including robust demand, strong bookings, solid pricing, and increased onboard spending. Analysts believe these trends could help the major operators—Norwegian, Royal Caribbean, and Carnival—achieve near-term growth.

Carnival on Tuesday announced the addition of new itineraries for seven of its ships set to sail in 2026 through 2027. Destinations include Half Moon Cay, a small private island in the Bahamas.

Meanwhile, Southwest Airlines, which also stands to benefit from improving travel demand, plans to meet with activist investor Elliott Investment Management on Sept. 6. Elliott remains committed to pushing for leadership changes at the airline. Its shares also rose today.

Travel platform Expedia beat quarterly estimates in its most recent report, released Aug. 8, boosted by strong demand in international markets. At the time, Expedia warned of challenging macroeconomic conditions and a potential weakening of demand, but the more recent strength from Trip.com could suggest a stabilization in the market.

Read more on Investopedia

Shares of Hanesbrands (HBI) gained Tuesday after UBS boosted its price target on the stock to $6.50 from $5 while maintaining a "neutral" rating.

reported that UBS analyst Jay Sole wrote that the apparel maker could be at “a major inflection point” as Chief Executive Officer (CEO) Stephen Bratspies has increased spending on product innovation and marketing.

In addition, the sale of Hanesbrands' Champion business is scheduled to close before the end of the year, and that could put the company's earnings before interest and taxes (EBIT) margin at 15%, reported. The $1.2 billion deal with Authentic Brands Group was announced in June. 

quoted Sole as saying that after meeting with management, “we believe HBI has an opportunity to flip the narrative around the stock for the first time in many years.” However, he kept the company's stock rating at neutral until Hanesbrands shows it can execute its strategy.

Hanesbrands shares traded Tuesday at their highest level since early 2023, rising 5.7% to $6.65 at close.

Read more on Investopedia

A lady has being heartbroken after discovering what her boyfriend saved her contact as on his phone.

The lady has discovered that her boyfriend saved her number with son and this has left heartbroken.

Continue reading on Instablog